DHA Clinical Pharmacy exam questions
Pharmacotherapy, TDM, renal and hepatic dosing, critical care and ID.
Card checkout is being set up. We send it directly, usually the same day.
What is riding on this exam
One failed attempt costs you the fee again, plus months of delay on your licence, your visa and your start date. This bank costs about a third of one exam fee.
Pass marks at a glance: DHA exam codes and pass marks for all written exams in one sourced table.
DHA Clinical Pharmacy exam at a glance
- Exam code
- PHO5482
- Questions
- 150 MCQs
- Duration
- 3 hours
- Pass mark
- 70%
- Fee per attempt
- USD 240 (about AED 880)
- Result
- Pass or fail, no score
From the DHA CBT Guideline, Sep 2026. Delivered by Prometric; three attempts in total across the UAE authorities. Full DHA exam guide.
Try two questions from this bank
Original questions from the bank - pick an answer to see the rationale and reference.
Below which eGFR is metformin contraindicated?
Choose an answer to see the rationale.
A 55-year-old man without high bleeding risk has had PCI with a drug-eluting stent for NSTEMI. What is the default duration of dual antiplatelet therapy?
Choose an answer to see the rationale.
Not sure where you stand? Sit 12 of these questions free, timed at real exam pace, and see which domains you are weakest in.
Take the free mock exam →Liked those? The full bank has 450 questions at this standard - every one with a rationale and a reference.
Get the full bank - AED 289What's inside
- ✓3 full-length papers (~150 Q each)
- ✓450 questions, no overlap between papers
- ✓Four options, one unambiguous best answer
- ✓A full rationale on every question
- ✓A real guideline or textbook reference
- ✓Every sub-topic in the published blueprint
The Clinical Pharmacy exam in every GCC country
| Regulator | Exam | Format | Pass mark | Fee per attempt | Practise |
|---|---|---|---|---|---|
| DHA Dubai | Clinical Pharmacy (PHO5482) | 150 MCQs in 3 hours | 70% | USD 240 (about AED 880) | DHA questions → |
| DOH Abu Dhabi, Al Ain and Al Dhafra | DOH licensing exam Regulator-wide format | Written + oral/OSCE | Pass / fail only | Not published | DOH questions → |
| MOHAP Northern Emirates - Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah | MOHAP licensing exam Regulator-wide format | Computer-based | Not published | Not published | MOHAP questions → |
| SHA Emirate of Sharjah | SHA licensing exam Regulator-wide format | Set at assessment | Not published | Not published | SHA questions → |
| SCFHS Kingdom of Saudi Arabia | SCFHS licensing exam Regulator-wide format | 200 MCQs, 240 min | 500-560 of 800 | Not published | SCFHS questions → |
| QCHP State of Qatar | QCHP licensing exam Regulator-wide format | 150 MCQs, 3 hrs | 50-65% | Not published | QCHP questions → |
| NHRA Kingdom of Bahrain | NHRA licensing exam Regulator-wide format | Prometric CBT | Not published | Not published | NHRA questions → |
| OMSB Sultanate of Oman | OMSB licensing exam Regulator-wide format | Computer-based OC exam | Not published | Not published | OMSB questions → |
| Kuwait MOH State of Kuwait | Kuwait MOH licensing exam Regulator-wide format | 150 MCQs, 170 min | 60-70% | Not published | Kuwait MOH questions → |
exact exam published for Clinical Pharmacy
From each regulator's own exam pages; anything a regulator does not publish says so. Assessment mode also depends on your licence title, so confirm your route on your eligibility notice.
Try 15 free Clinical Pharmacy questions with answersDifferent from the samples on this page - each with a full explanationStart →What the Clinical Pharmacy exam covers
The published blueprint for this exam breaks into 9 domains and 57 testable sub-topics. Our bank covers every one of them - here is the full map, so you can see exactly what you are expected to know.
Cardiovascular Pharmacotherapy~15%7 topics
- Heart failure with reduced ejection fraction: guideline-directed therapy
- Acute coronary syndrome: antiplatelets and secondary prevention
- Atrial fibrillation: rate, rhythm and stroke prevention
- Hypertension: drug selection in comorbidities
- Dyslipidaemia and statin drug interactions
- Amiodarone and digoxin interactions and toxicity
- Hypertensive urgency and emergency
Infectious Diseases and Antimicrobial Stewardship~15%8 topics
- Vancomycin AUC-guided dosing
- Aminoglycoside extended-interval dosing
- Beta-lactam allergy assessment and cross-reactivity
- Resistant gram-negative infections: ESBL and carbapenemase producers
- Clostridioides difficile infection treatment
- Urinary tract infection management
- Community-acquired and hospital-acquired pneumonia
- Stewardship interventions: de-escalation, IV-to-oral switch, duration
Critical Care, Renal and Hepatic Considerations~12%6 topics
- Estimating renal function: Cockcroft-Gault and eGFR
- Drug dosing in CKD, dialysis and CRRT
- Electrolyte emergencies: hyperkalaemia and hyponatraemia
- Sedation, analgesia and delirium in the ICU
- Stress ulcer and VTE prophylaxis in critical illness
- Dosing in hepatic impairment
Pharmacokinetics and Therapeutic Drug Monitoring~12%6 topics
- Half-life, steady state and accumulation
- Loading and maintenance dose calculations
- Non-linear (Michaelis-Menten) kinetics of phenytoin
- Protein binding and albumin correction
- Sampling times for digoxin, aminoglycosides and vancomycin
- Drug interactions via CYP450 and P-glycoprotein
Endocrine, Respiratory and Gastrointestinal Pharmacotherapy~10%6 topics
- Diabetes: inpatient insulin and cardiorenal agents
- Thyroid replacement and drug absorption interactions
- Asthma: GINA stepwise therapy
- COPD: GOLD inhaler escalation
- Helicobacter pylori eradication regimens
- Inflammatory bowel disease and proton pump inhibitor stewardship
Oncology, Haematology and Anticoagulation~12%7 topics
- Direct oral anticoagulant dosing and dose reduction criteria
- Warfarin management and reversal
- Heparin-induced thrombocytopenia
- Chemotherapy supportive care: antiemetics, tumour lysis syndrome
- High-dose methotrexate and leucovorin rescue
- Febrile neutropenia empirical therapy
- Safe handling of cytotoxic drugs
Neurology, Psychiatry and Pain~8%6 topics
- Opioid conversion and equianalgesic dosing
- Serotonin syndrome and drug combinations
- Lithium toxicity and interacting drugs
- Antiepileptic drug interactions and monitoring
- Antipsychotic adverse effects and monitoring
- Neuropathic pain pharmacotherapy
Special Populations~8%5 topics
- Paediatric weight-based dosing
- Older adults: Beers Criteria and deprescribing
- Pregnancy and lactation drug safety
- Obesity dosing weights
- Renal and hepatic dose adjustment in older adults
Medication Safety, Evidence-Based Practice and Ethics~8%6 topics
- High-alert medications and look-alike sound-alike drugs
- Medication error classification and reporting
- Medication reconciliation at transitions of care
- Critical appraisal: NNT, relative and absolute risk
- Pharmacovigilance and adverse drug reaction reporting
- Professional ethics, confidentiality and conflicts of interest
6 worked Clinical Pharmacy practice questions
Original exam-style questions from the bank, spread across the blueprint domains. They are not real or recalled exam questions. Try each one, then open the answer for the rationale and reference. None of them appear in the free mock exam, so reading them will not spoil it.
Question 1 · Cardiovascular Pharmacotherapy
An 80-year-old on digoxin 125 micrograms daily for AF rate control is started on amiodarone. What adjustment is recommended?
- AReduce the digoxin dose by about half
- BIncrease the digoxin dose by half
- CNo change is needed
- DStop amiodarone after loading
Show answer and explanation
Correct answer: A. Reduce the digoxin dose by about half
Amiodarone inhibits P-glycoprotein and reduces digoxin clearance, roughly doubling digoxin concentrations, so the digoxin dose is reduced by about half with level monitoring. Leaving the dose unchanged risks digoxin toxicity, particularly in an older patient.
Reference: Amiodarone Prescribing Information; Stockley's Drug Interactions, 12th ed.
Question 2 · Critical Care, Renal and Hepatic Considerations
A patient on dialysis has potassium 7.1 mmol/L with peaked T waves and widened QRS complexes. What should be given first?
- AIV calcium gluconate
- BOral sodium polystyrene sulfonate
- CIV furosemide
- DOral sodium bicarbonate
Show answer and explanation
Correct answer: A. IV calcium gluconate
IV calcium gluconate stabilises the myocardial membrane within minutes and is the first step when hyperkalaemia causes ECG changes. Insulin with glucose then shifts potassium into cells; resins act too slowly for an emergency.
Reference: UK Kidney Association Clinical Practice Guideline: Treatment of Acute Hyperkalaemia in Adults 2023
Question 3 · Endocrine, Respiratory and Gastrointestinal Pharmacotherapy
A patient's TSH has risen after she started calcium carbonate and ferrous sulfate taken together with her morning levothyroxine. What is the most appropriate advice?
- ATake levothyroxine at least 4 hours apart from calcium and iron
- BDouble the levothyroxine dose
- CStop the calcium and iron permanently
- DTake levothyroxine with breakfast and the minerals
Show answer and explanation
Correct answer: A. Take levothyroxine at least 4 hours apart from calcium and iron
Calcium and iron bind levothyroxine in the gut and reduce its absorption, so separating them by at least 4 hours usually corrects the problem. Increasing the dose without separating the drugs leads to variable control.
Reference: ATA Guidelines for the Treatment of Hypothyroidism 2014
Question 4 · Infectious Diseases and Antimicrobial Stewardship
A 58-year-old has bacteraemia from a urinary source with ESBL-producing Klebsiella pneumoniae, susceptible to piperacillin/tazobactam and meropenem. What is the preferred definitive therapy?
- APiperacillin/tazobactam
- BMeropenem
- CCeftriaxone
- DAmoxicillin/clavulanate
Show answer and explanation
Correct answer: B. Meropenem
A carbapenem is preferred for ESBL bloodstream infection because the MERINO trial showed higher 30-day mortality with piperacillin/tazobactam even when reported susceptible. Ceftriaxone is hydrolysed by ESBLs and is unreliable.
Reference: IDSA Guidance on Treatment of Antimicrobial-Resistant Gram-Negative Infections 2024
Question 5 · Neurology, Psychiatry and Pain
A woman stable on lithium for bipolar disorder develops coarse tremor, vomiting and confusion 2 weeks after a new antihypertensive was added. Her lithium level is 1.9 mmol/L. Which drug most likely caused this?
- AAmlodipine
- BDoxazosin
- CHydrochlorothiazide
- DAtenolol
Show answer and explanation
Correct answer: C. Hydrochlorothiazide
Thiazide diuretics reduce renal lithium clearance by increasing proximal sodium and lithium reabsorption, raising lithium levels by around 25-40%. ACE inhibitors and NSAIDs also raise lithium, while amlodipine, doxazosin and atenolol have no clinically important effect on its clearance.
Reference: Stockley's Drug Interactions, 12th ed.
Question 6 · Oncology, Haematology and Anticoagulation
An 82-year-old woman with non-valvular AF weighs 58 kg and has a serum creatinine of 95 micromol/L. What apixaban dose is appropriate?
- A5 mg twice daily
- B2.5 mg once daily
- C10 mg twice daily
- D2.5 mg twice daily
Show answer and explanation
Correct answer: D. 2.5 mg twice daily
Apixaban is reduced to 2.5 mg twice daily in AF when at least two of age 80 or over, weight 60 kg or less, or creatinine 133 micromol/L or more are present; she meets the age and weight criteria. Once-daily dosing is not a licensed regimen for apixaban.
Reference: Apixaban Summary of Product Characteristics; EHRA Practical Guide on NOACs 2021
Last reviewed September 2026
About these questions: every question is original, written to the published blueprint, with a rationale and a reference. No recalled or leaked exam content is used. How we write our questions.
Before you book your exam
Frequently asked questions
Are these real Clinical Pharmacy exam questions?
How many questions are in the Clinical Pharmacy bank?
What is the pass mark for the DHA Clinical Pharmacy exam?
How many questions are in the DHA Clinical Pharmacy exam, and how long is it?
How much does the DHA Clinical Pharmacy exam cost?
How many attempts do I get?
Does this cover DHA, DOH, MOHAP and SCFHS?
How do I receive it?
Still unsure whether you even need this exam?
Your route depends on your profession, your licence title and the authority. We have guided over 1,000 professionals through GCC licensing - tell us your situation and we will confirm exactly what you need to sit.